Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Virpax Pharmaceuticals Inc (NASDAQ: VRPX)

 
VRPX Technical Analysis
5
As on 13th Jun 2025 VRPX STOCK Price closed @ 0.23 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.32 & Strong Sell for SHORT-TERM with Stoploss of 0.74 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VRPXSTOCK Price

Open 0.23 Change Price %
High 0.23 1 Day 0.00 0.00
Low 0.23 1 Week -0.02 -8.00
Close 0.23 1 Month -0.04 -14.81
Volume 107 1 Year -0.13 -36.11
52 Week High 4.95 | 52 Week Low 0.10
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
HCTI 0.03 50.00%
PLUG 1.49 28.45%
NVDA 157.99 0.15%
SOFI 18.21 6.00%
LMDX 0.02 0.00%
NCNA 0.06 -33.33%
LCID 2.11 -0.47%
AKTS 0.04 0.00%
HOOD 93.63 12.77%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
TBIO 0.30 500.00%
NBSTU 12.99 220.74%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
SRAX 0.01 -66.67%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
HEPA 0.12 -62.50%
 
 
VRPX
Daily Charts		 VRPX
Intraday Charts		 Whats New @
Bazaartrend		 VRPX
Free Analysis
 
VRPX Important Levels Intraday
RESISTANCE0.23
RESISTANCE0.23
RESISTANCE0.23
RESISTANCE0.23
RESISTANCE0.23
RESISTANCE0.23
RESISTANCE0.23
RESISTANCE0.23
 
VRPX Forecast July 2025
Share
4th UP Forecast0.52
3rd UP Forecast0.43
2nd UP Forecast0.37
1st UP Forecast0.31
1st DOWN Forecast0.15
2nd DOWN Forecast0.09
3rd DOWN Forecast0.03
4th DOWN Forecast-0.06
 
VRPX Weekly Forecast
4th UP Forecast0.38
3rd UP Forecast0.33
2nd UP Forecast0.30
1st UP Forecast0.27
1st DOWN Forecast0.19
2nd DOWN Forecast0.16
3rd DOWN Forecast0.13
4th DOWN Forecast0.08
 
VRPX Forecast2025
4th UP Forecast10.6
3rd UP Forecast7.27
2nd UP Forecast5.22
1st UP Forecast3.16
1st DOWN Forecast-2.7
2nd DOWN Forecast-4.76
3rd DOWN Forecast-6.81
4th DOWN Forecast-10.14
 
 
VRPX Other Details
Segment EQ
Market Capital 49320992.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VRPX Address
VRPX
 
VRPX Latest News
 
Your Comments and Response on Virpax Pharmaceuticals Inc
 
VRPX Business Profile
Virpax Pharmaceuticals, Inc., a preclinical stage biopharmaceutical company, develops and manufactures non-opioid and non-addictive pharmaceutical products using drug delivery systems for pain management. The company offers products, such as Epoladerm, a diclofenac metered-dose spray film for acute musculoskeletal pain; Probudur (LBL100), long-acting bupivacaine liposomal gel for postoperative pain management; OSF200 for chronic osteoarthritis of the knee; and NES100 (Envelta), an exogenous enkephalin intranasal spray for acute and chronic pain. It also develops PES200 for the management of post-traumatic stress disorder; and MMS019 high-density molecular masking spray to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2 (Covid-19). Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania. Address: 1055 Westlakes Drive, Berwyn, PA, United States, 19312
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service